CH
Insider
Cyrus Harmon
DirectorCyrus Harmon (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Olema Pharmaceuticals, Inc. (OLMA). The largest single filing was $291K of OLMA (25,000 sh across 2 lots, as filed), executed Jul 23.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$662K
shares × price, as filed
Last traded
Jul 24
Filed Jul 27
Median ADV $15.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $662K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
OLMA
Olema Pharmaceuticals, Inc.
OLMA · 0 buys · 3 sells
3 filings
Recent filings
OLMASALE
Olema Pharmaceuticals, Inc.
View filing →
$291K25,000 sh across 2 lots
Exec Jul 23
Filed Jul 27 · 7:30 PM ET OLMASALE Olema Pharmaceuticals, Inc. View filing → $269K
10,000 sh × $26.88
Exec Jan 20
Filed Jan 21 · 5:30 PM ET OLMASALE Olema Pharmaceuticals, Inc. View filing → $102K
3,489 sh × $29.12
Exec Jan 14
Filed Jan 16 · 5:30 PM ET